Company: SHPH
Filing Date: 2025-03-19
Form Type: PRE 14A
Source: 0001493152-25-010886
Chunk: 12

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-19
Form: PRE 14A
Chunk 12
---
 director offer letters, with each receiving compensation on an annual basis consisting of (i) $25,000 in cash, payable in quarterly installments and (ii) $100,000 in RSUs following initial appointment, with the per share value of such RSUs determined as of the grant date, with additional RSUs awards to be determined annually. Pursuant to director offer letters entered into between each director and our Company, the RSUs vest over a three-year period in one third increments on each of the first, second and third anniversary following the appointment. In addition, non-employee directors are also reimbursed for out-of-pocket costs incurred in connection with attending meetings.

Proposal 1: Election of Directors

| What                                  
 am I voting on and how should I vote? |     | You                                                                                                                                
 are being asked to elect five (5) directors at the Annual Meeting. Each of the directors                                           
 elected at the Annual Meeting will commence their term at the end of the Annual Meeting and                                        
 serve until the next Annual Meeting, or until a successor has been elected and qualified,                                          
 or until such director’s earlier resignation or removal.                                                                           
 We                                                                                                                                 
 believe that each of the nominees brings a set of experience and qualifications that positions our Board of Directors well to lead 
 the Company in the best interest of stockholders.                                                                                  
 The                                                                                                                                
 Board of Directors therefore recommends you vote “FOR” each of the nominees set forth below.                                       |

Nominees

| 1. | Anatoly            
 Dritschilo, M.D.   |
| 2. | Steve              
 Richards, MBA, CPA |
| 3. | George             
 Scorsis            |
| 4. | Oleh               
 Nabyt              |
| 5. | Joseph             
 Tung               |

Vote Required

One-third of the shares present in person or by proxy and entitled to vote at our 2025 Annual Meeting is required to approve Proposal No. 1.

| 11 |

Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm

ForvisMazars, LLP served as the Company’s independent registered public accounting firm since March 21, 2023 and has audited the Company’s financial statements as incorporated in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Fees Paid to the Independent Public Accounting Firm

The following table represents fees for professional audit services for the audit of the Company’s annual financial statements for the fiscal years